United States Psoriatic arthritis drug Market Report 2016

December 2016 | 104 pages | ID: U798FF685B8EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Psoriatic arthritis drug

Revenue, means the sales value of Psoriatic arthritis drug

This report studies sales (consumption) of Psoriatic arthritis drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Abbvie
• Janssen
• Amgen
• Pfizer
• Eli-lilly
• Celgene

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• TNF Inhibitors
• PDE4 Inhibitors
• Interleukin Blockers
• Others

Split by applications, this report focuses on sales, market share and growth rate of Psoriatic arthritis drug in each application, can be divided into

• Mild Psoriatic arthritis drug
• Moderate Psoriatic arthritis drug
• Severe Psoriatic arthritis drug

Contents

United States Psoriatic arthritis drug Market Report 2016

1 PSORIATIC ARTHRITIS DRUG OVERVIEW

1.1 Product Overview and Scope of Psoriatic arthritis drug
1.2 Classification of Psoriatic arthritis drug
  1.2.1 TNF Inhibitors
  1.2.2 PDE4 Inhibitors
  1.2.3 Interleukin Blockers
  1.2.4 Others
1.3 Application of Psoriatic arthritis drug
  1.3.1 Mild Psoriatic arthritis drug
  1.3.2 Moderate Psoriatic arthritis drug
  1.3.3 Severe Psoriatic arthritis drug
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Psoriatic arthritis drug (2011-2021)
  1.4.1 United States Psoriatic arthritis drug Sales and Growth Rate (2011-2021)
  1.4.2 United States Psoriatic arthritis drug Revenue and Growth Rate (2011-2021)

2 UNITED STATES PSORIATIC ARTHRITIS DRUG COMPETITION BY MANUFACTURERS

2.1 United States Psoriatic arthritis drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Psoriatic arthritis drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Psoriatic arthritis drug Average Price by Manufactures (2015 and 2016)
2.4 Psoriatic arthritis drug Market Competitive Situation and Trends
  2.4.1 Psoriatic arthritis drug Market Concentration Rate
  2.4.2 Psoriatic arthritis drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES PSORIATIC ARTHRITIS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Psoriatic arthritis drug Sales and Market Share by Type (2011-2016)
3.2 United States Psoriatic arthritis drug Revenue and Market Share by Type (2011-2016)
3.3 United States Psoriatic arthritis drug Price by Type (2011-2016)
3.4 United States Psoriatic arthritis drug Sales Growth Rate by Type (2011-2016)

4 UNITED STATES PSORIATIC ARTHRITIS DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Psoriatic arthritis drug Sales and Market Share by Application (2011-2016)
4.2 United States Psoriatic arthritis drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES PSORIATIC ARTHRITIS DRUG MANUFACTURERS PROFILES/ANALYSIS

5.1 Abbvie
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Psoriatic arthritis drug Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Abbvie Psoriatic arthritis drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Janssen
  5.2.2 Psoriatic arthritis drug Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Janssen Psoriatic arthritis drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Amgen
  5.3.2 Psoriatic arthritis drug Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Amgen Psoriatic arthritis drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Pfizer
  5.4.2 Psoriatic arthritis drug Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Pfizer Psoriatic arthritis drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Eli-lilly
  5.5.2 Psoriatic arthritis drug Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Eli-lilly Psoriatic arthritis drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Celgene
  5.6.2 Psoriatic arthritis drug Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Celgene Psoriatic arthritis drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview

6 PSORIATIC ARTHRITIS DRUG MANUFACTURING COST ANALYSIS

6.1 Psoriatic arthritis drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Psoriatic arthritis drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Psoriatic arthritis drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Psoriatic arthritis drug Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES PSORIATIC ARTHRITIS DRUG MARKET FORECAST (2016-2021)

10.1 United States Psoriatic arthritis drug Sales, Revenue Forecast (2016-2021)
10.2 United States Psoriatic arthritis drug Sales Forecast by Type (2016-2021)
10.3 United States Psoriatic arthritis drug Sales Forecast by Application (2016-2021)
10.4 Psoriatic arthritis drug Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Psoriatic arthritis drug
Table Classification of Psoriatic arthritis drug
Figure United States Sales Market Share of Psoriatic arthritis drug by Type in 2015
Figure TNF Inhibitors Picture
Figure PDE4 Inhibitors Picture
Figure Interleukin Blockers Picture
Figure Others Picture
Table Application of Psoriatic arthritis drug
Figure United States Sales Market Share of Psoriatic arthritis drug by Application in 2015
Figure Mild Psoriatic arthritis drug Examples
Figure Moderate Psoriatic arthritis drug Examples
Figure Severe Psoriatic arthritis drug Examples
Figure United States Psoriatic arthritis drug Sales and Growth Rate (2011-2021)
Figure United States Psoriatic arthritis drug Revenue and Growth Rate (2011-2021)
Table United States Psoriatic arthritis drug Sales of Key Manufacturers (2015 and 2016)
Table United States Psoriatic arthritis drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Psoriatic arthritis drug Sales Share by Manufacturers
Figure 2016 Psoriatic arthritis drug Sales Share by Manufacturers
Table United States Psoriatic arthritis drug Revenue by Manufacturers (2015 and 2016)
Table United States Psoriatic arthritis drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Psoriatic arthritis drug Revenue Share by Manufacturers
Table 2016 United States Psoriatic arthritis drug Revenue Share by Manufacturers
Table United States Market Psoriatic arthritis drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Psoriatic arthritis drug Average Price of Key Manufacturers in 2015
Figure Psoriatic arthritis drug Market Share of Top 3 Manufacturers
Figure Psoriatic arthritis drug Market Share of Top 5 Manufacturers
Table United States Psoriatic arthritis drug Sales by Type (2011-2016)
Table United States Psoriatic arthritis drug Sales Share by Type (2011-2016)
Figure United States Psoriatic arthritis drug Sales Market Share by Type in 2015
Table United States Psoriatic arthritis drug Revenue and Market Share by Type (2011-2016)
Table United States Psoriatic arthritis drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Psoriatic arthritis drug by Type (2011-2016)
Table United States Psoriatic arthritis drug Price by Type (2011-2016)
Figure United States Psoriatic arthritis drug Sales Growth Rate by Type (2011-2016)
Table United States Psoriatic arthritis drug Sales by Application (2011-2016)
Table United States Psoriatic arthritis drug Sales Market Share by Application (2011-2016)
Figure United States Psoriatic arthritis drug Sales Market Share by Application in 2015
Table United States Psoriatic arthritis drug Sales Growth Rate by Application (2011-2016)
Figure United States Psoriatic arthritis drug Sales Growth Rate by Application (2011-2016)
Table Abbvie Basic Information List
Table Abbvie Psoriatic arthritis drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbvie Psoriatic arthritis drug Sales Market Share (2011-2016)
Table Janssen Basic Information List
Table Janssen Psoriatic arthritis drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Psoriatic arthritis drug Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Psoriatic arthritis drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Psoriatic arthritis drug Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Psoriatic arthritis drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Psoriatic arthritis drug Sales Market Share (2011-2016)
Table Eli-lilly Basic Information List
Table Eli-lilly Psoriatic arthritis drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli-lilly Psoriatic arthritis drug Sales Market Share (2011-2016)
Table Celgene Basic Information List
Table Celgene Psoriatic arthritis drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celgene Psoriatic arthritis drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Psoriatic arthritis drug
Figure Manufacturing Process Analysis of Psoriatic arthritis drug
Figure Psoriatic arthritis drug Industrial Chain Analysis
Table Raw Materials Sources of Psoriatic arthritis drug Major Manufacturers in 2015
Table Major Buyers of Psoriatic arthritis drug
Table Distributors/Traders List
Figure United States Psoriatic arthritis drug Production and Growth Rate Forecast (2016-2021)
Figure United States Psoriatic arthritis drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Psoriatic arthritis drug Production Forecast by Type (2016-2021)
Table United States Psoriatic arthritis drug Consumption Forecast by Application (2016-2021)